Publication: A validated liquid chromatography-tandem mass spectrometry method for the determination of methyl gallate and pentagalloyl glucopyranose: Application to pharmacokinetic studies
Issued Date
2015-04-01
Resource Type
ISSN
1873376X
15700232
15700232
Other identifier(s)
2-s2.0-84923037533
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Vol.986-987, (2015), 12-17
Suggested Citation
Pimsumon Jiamboonsri, Pimolpan Pithayanukul, Rapepol Bavovada, Song Gao, Ming Hu A validated liquid chromatography-tandem mass spectrometry method for the determination of methyl gallate and pentagalloyl glucopyranose: Application to pharmacokinetic studies. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Vol.986-987, (2015), 12-17. doi:10.1016/j.jchromb.2015.02.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35476
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A validated liquid chromatography-tandem mass spectrometry method for the determination of methyl gallate and pentagalloyl glucopyranose: Application to pharmacokinetic studies
Other Contributor(s)
Abstract
© 2015 Elsevier B.V. Methyl gallate (MG) and pentagalloyl glucopyranose (PGG) are bioactive phenolic compounds that are widely distributed in herbs and plant foods. Their potential activities include anti-oxidant, anti-inflammatory, anti-cancer, anti-bacterial and anti-viral activities. However, knowledge concerning the pharmacokinetic characteristics of MG and PGG is limited. The purpose of this study was to develop a sensitive and reproducible ultra-performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) method to simultaneously quantify MG and PGG in rat blood samples. The linear response ranges for MG and PGG were 0.0195-20 and 0.0390-20μM, respectively. The lower limit of quantification was 0.0195μM for MG and 0.0390μM for PGG. The intra- and inter-day variances were less than 15%, and accuracy was within 80-120%. This assay was successfully applied to pharmacokinetic studies in Sprague-Dawley rats after intraperitoneal administration of MG and PGG (20mg/kg). The values of areas under the blood concentration time curves (AUC0-24h) for MG and PGG were 109.9±73.40 and 38.78±24.53h*μM, respectively. The maximum blood concentrations (Cmax) of MG and PGG were 34.72±17.32 and 6.39±4.25μM, respectively. The time required to reach the maximum concentration (Tmax) was 0.85±0.70h for both MG and PGG. The values of the elimination rate constant (Ke), elimination half-life (t1/2), volume of distribution (Vd), clearance (Cl) and mean resident time (MRTlast) were 0.056±0.032h-1, 17.50±12.25h, 530.95±247.54L/kg, 159.91±76.05L/h/kg, 8.71±2.53h for MG and 0.023±0.012h-1, 38.66±22.89h, 7838.89±3474.72L/kg, 30.98±21.73L/h/kg, 12.47±2.77h for PGG, respectively. In conclusion, a UPLC-MS/MS method was fully validated over a wide linear range and used to quantify the levels of MG and PGG in pharmacokinetic studies of MG and PGG in rats. The main advantages of this method are the use of small blood volumes (10μL), rapid analysis (5min) and excellent recoveries.